GLP-1 medications such as Ozempic and Wegovy have transformed treatment for Type 2 diabetes and obesity, but new research suggests doctors may need to pay closer attention to bone health, especially ...
Correspondence to Dr Margo Mountjoy, Department of Family Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON N2G 1C5, Canada; mmsportdoc{at}mcmaster.ca In 2014, the ...
Valued at $1.6 billion, a tiny start-up called Axiom is building A.I. systems that can check for mistakes. By Cade Metz Following rivals like Amazon and OpenAI, Microsoft is upgrading its artificially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results